These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1905 related articles for article (PubMed ID: 19152397)

  • 21. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.
    Miailhes P; Trabaud MA; Pradat P; Lebouché B; Chevallier M; Chevallier P; Zoulim F; Trepo C
    Clin Infect Dis; 2007 Sep; 45(5):624-32. PubMed ID: 17682999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Should patients infected with HIV be screened for occult hepatitis B?].
    Marque-Juillet S; Benghalia K; Monnier S; Fernand-Laurent C; Mazeron MC; Harzic M
    Pathol Biol (Paris); 2010 Apr; 58(2):e39-42. PubMed ID: 19854582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A; Banifazl M; Kalantar E; Eslamifar A; Ahmadi F; Razeghi E; Atabak S; Amini M; Khadem-Sadegh A; Ramezani A
    Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
    Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
    J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis.
    Motta JS; Mello FC; Lago BV; Perez RM; Gomes SA; Figueiredo FF
    J Gastroenterol Hepatol; 2010 Jan; 25(1):101-6. PubMed ID: 19817965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A cross-sectional survey of occult hepatitis B virus infection in HIV-infected patients].
    Ma JX; Lu HZ; Wang JR; Zhang RF; Zheng YF; Liu L; Qi TK; Shen YZ
    Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):574-7. PubMed ID: 19035170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
    Matthews GV; Bartholomeusz A; Locarnini S; Ayres A; Sasaduesz J; Seaberg E; Cooper DA; Lewin S; Dore GJ; Thio CL
    AIDS; 2006 Apr; 20(6):863-70. PubMed ID: 16549970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
    Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study.
    Sagnelli E; Imparato M; Coppola N; Pisapia R; Sagnelli C; Messina V; Piai G; Stanzione M; Bruno M; Moggio G; Caprio N; Pasquale G; Del Vecchio Blanco C
    J Med Virol; 2008 Sep; 80(9):1547-53. PubMed ID: 18649338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.
    Shetty K; Hussain M; Nei L; Reddy KR; Lok AS
    Liver Transpl; 2008 Apr; 14(4):534-40. PubMed ID: 18324677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
    J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
    Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea.
    Kim SM; Lee KS; Park CJ; Lee JY; Kim KH; Park JY; Lee JH; Kim HY; Yoo JY; Jang MK
    J Infect; 2007 Feb; 54(2):185-91. PubMed ID: 16564573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 96.